Reducing the size of drug particles enhances their uptake into cells leading to more effective tumor treatment.

Reducing the size of drug particles enhances their uptake into cells leading to more effective tumor treatment.
A Joint Virtual Issue between the European Journal of Immunology and Cytometry Part A presents several publications on the latest developments in cancer diagnostics and immunotherapy.
Transit-amplifying cells TACs have long been viewed as a passive population that just cranks out tissues. A new review challenges this view.
This month’s top Advanced Healthcare Materials papers.
Chimeric RNAs can be generated by not only chromosomal rearrangements at the DNA level, but also intergenic splicing at the RNA level. Chimeric RNAs are demonstrated to be not the elusive features of cancer cells, but also present in normal physiology and with diverse functions.
This month’s top Advanced Healthcare Materials papers.
This week’s Advanced Healthcare Materials covers.
Cancers that kill are the paradigm that most people know, but there’s more to cancer than just that…
A new targeted chemotherapeutic nano-medicine NANOPt-pan, composed of Panitumumab and DACHPt (the active form of Oxaliplatin), could passively and actively target EGFR over-expressing tumors and effectively target both KRAS wild type- and mutant-tumors.
Cancer is a disease that is responsible for an overwhelming number of deaths worldwide. The conventional therapeutic approaches used for treatment can be ineffective. inducing prominent side effects.